Olga Vikhammer Gran
University of Tromsø
10 Papers
58 Citations
Olga Vikhammer Gran is an academic researcher from University of Tromsø. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 5, co-authored 10 publications. Previous affiliations of Olga Vikhammer Gran include University Hospital of North Norway.
Chat about Author
Papers
Epidemiology of venous thromboembolism in hematological cancers: The Scandinavian Thrombosis and Cancer (STAC) cohort.
Inger Lise Gade,Sigrid Kufaas Brækkan,Inger Anne Næss,John-Bjarne Hansen,Frits R. Rosendaal,Suzanne C. Cannegieter,Kim Overvad,Hilde Jensvoll,Jens Hammerstrøm,Olga Vikhammer Gran,Anne Tjønneland,Søren Risom Kristensen,Marianne Tang Severinsen +12 more
TL;DR: The IR of VTE was higher in all types of cancer except for indolent lymphoma but including chronic lymphocytic leukemia compared with reference subjects both during the first year after cancer diagnosis and 1-5years after diagnosis.
23
Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort
Kristine Blix,Kristine Blix,Olga Vikhammer Gran,Olga Vikhammer Gran,Marianne Tang Severinsen,Suzanne C. Cannegieter,Hilde Jensvoll,Hilde Jensvoll,Kim Overvad,Jens Hammerstrøm,Anne Tjønneland,Inger A Naess,Sigrid Kufaas Brækkan,Sigrid Kufaas Brækkan,Frits R. Rosendaal,Frits R. Rosendaal,Søren Risom Kristensen,John-Bjarne Hansen,John-Bjarne Hansen +18 more
TL;DR: The risk of VTE was influenced by the mortality rate and the time since cancer diagnosis, and competing risk by death should be taken into account when exploring VTE risk in cancer.
20
Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event
Hanne Skille,Benedikte Paulsen,Kristian Hveem,Maiken Elvestad Gabrielsen,Ben Michael Brumpton,Kristian Hindberg,Olga Vikhammer Gran,Frits R. Rosendaal,Frits R. Rosendaal,Sigrid Kufaas Brækkan,Sigrid Kufaas Brækkan,John-Bjarne Hansen,John-Bjarne Hansen +12 more
TL;DR: The role of combined prothrombotic genotypes in cancer‐related venous thromboembolism (VTE) is scarcely studied and the impact of a 5‐single nucleotide polymorphism (SNP) score on the risk of VTE in patients with and without cancer is investigated.
17
Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
Benedikte Paulsen,Hanne Skille,Erin N. Smith,Kristian Hveem,Maiken Elvestad Gabrielsen,Sigrid Kufaas Brækkan,Frits R. Rosendaal,Kelly A. Frazer,Olga Vikhammer Gran,John-Bjarne Hansen +9 more
TL;DR: Investigating the effect of the FGG variant and active cancer on the risk of venous thromboembolism found a synergistic effect was observed and homozygosity at the fibrinogen gamma gene yielded a synergism effect on therisk of VTE.
13
Occult cancer‐related first venous thromboembolism is associated with an increased risk of recurrent venous thromboembolism
Olga Vikhammer Gran,Sigrid Kufaas Brækkan,Sigrid Kufaas Brækkan,Benedikte Paulsen,Hanne Skille,Frits R. Rosendaal,Frits R. Rosendaal,John-Bjarne Hansen,John-Bjarne Hansen +8 more
TL;DR: The risk of VTE recurrence in occult‐, overt‐ and non‐cancer related first VTE had the highest risk, likely due to the advanced cancers.
9